Skip to content

Efficacy of intraoperative use of esketamine on postoperative chronic pain in orthopedic patients with preoperative anxiety and depression: a randomized controlled trial

Efficacy of intraoperative use of esketamine on postoperative chronic pain in orthopedic patients with preoperative anxiety and depression: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124319
Enrollment
Unknown
Registered
2026-05-11
Start date
2025-01-10
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain

Interventions

Esketamine Group:Esketamine group was injected with Esketamine 0.2 mg/kg by pump (diluted to 20ml with normal saline and pumped for 30min).
Saline Group:20ml of saline and pumped for 30min

Sponsors

Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Adults over 18 and under 65. 2. Orthopedic patients with moderate and severe pain after elective surgery. 3. Clear consciousness, no mental abnormality, primary school education or above, and can independently and accurately complete the evaluation of the scale in the experiment. 4. Patients with ASA grade I-II 5. Anxiety and depression patients with hospital anxiety and depression scale > 7.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to the active ingredients of Esketamine or all auxiliary materials. 2. Patients with blood pressure or serious risk of increased intracranial pressure. 3. Patients with poorly controlled or untreated hypertension 4. Untreated or under-treated patients with hyperthyroidism. 5. Patients with ischemic heart disease or arrhythmia. 6. Patients who have or have had a history of mental disorders 7. Patients with glaucoma or other diseases that can't bear the increase of intraocular pressure. 8. Patients with severe liver and renal insufficiency 9. Pregnant and lactating patients

Design outcomes

Primary

MeasureTime frame
Postoperative chronic pain;

Secondary

MeasureTime frame
Acute postoperative pain;Postoperative anxiety and depression;General data;Vital signs and general monitoring indicators;Assessment of restlessness after tracheal tube removal;Postoperative recovery quality assessment;Postoperative nausea and vomiting;

Countries

China

Contacts

Public ContactHuang Changsheng

Xiangya Hospital, Central South University

changsheng.huang@csu.edu.cn+86 159 7417 2150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026